Skip to main content

JSW Steel

An equity analyst tracking metals and steel sector cautions against the bullish reports being published by a couple of bro-kerage houses for JSW Steel. No doubt this leading steel com-pany is well managed, but the analyst opines that the steel in-dustry is still facing several challenges globally, and it may take several years to recover. In these circumstances, the chances ofthe scrip crossing Rs. 1200-mark appear to be remote. Little wonder, in the second quarter of FY 16, the company’s saleshave come down by 21.5 per cent to Rs. 10,743 crore as com-
pared to Rs. 13,692 crore in the corresponding quarter last year and the profit at net level has nosedived from Rs 749 crore to Rs 118 crore, a drop of 84.2 per cent. The second quarter results would have been worse but for the good show by a couple of overseas subsidiaries. The disastrous economic meltdown in China will not allow the steel industry to stage a recovery for 6 to & quarters, it is widely believed. The JSW stock price will hover between Rs. 800 and Rs. 1000, the analyst insists.

Comments

Popular posts from this blog

Cipla Ltd ( Ready To Fly In Sky No One Catch It)

Cipla Ltd. (BSE Code: 500087) (CMP: Rs.654.95) (FV: Rs.2) (TGT: Rs.1500)  Cipla Ltd is a pharmaceutical company with business units focused on Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company offers APIs, formulations and veterinary products. As of 31 March 2015, Cipla offered services across five continents and in countries like India, South Africa, Europe and North America, among others. It offers over 1,000 products across 120 countries that treat cardiovascular diseases, children’s health, dermatology and cosmetology, diabetes, Human Immunodeficiency Virus/Acquired Immuno Deficiency syndrome (HIV/AIDS), infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women’s health. It also offers veterinary products in categories such as companion, equine, general care, livestock and poultry. Cipla’s UK arm has entered into an agreement to acquire two US-based companies...

Vinati Organics (BSE Code: 524200 )

Vinati  Organics  (BSE Code: 524200   ) A leading brokerage house has advised its clients to invest in Vinati Organics, the largest manufacturer of ISO Butylbenzene (IBB) and ATBS in the world. The company exports its products to 22 countries with export earnings contributing to around 65 per cent of its total turnover. The company is growing from strength to strength and during the last five years, its sales turnover has more than doubled, from Rs 325 crore in fiscal 2011 to Rs 772 crore in fiscal 2015 and the net profit shoot up by around 125 per cent. The company is doing quite well even in the current year also with the half year net profit amounting to Rs 62 crore as compared to Rs 52 crore in the corresponding period last year.

SSPDL LTD Big Play

SSPDL LTD  It is a small company having presence in South India. It has presence in Chennai, Hyderabad, Kerala and Bangalore. Only BSE listed company. But Circuit Filter is at 20%. From Annual Report: Company is primarily focusing on the development of land, plotted lands, mid-size houses, etc. and reduce the construction contracts work. In view of the projects of the Company under execution and in pipe line, the management is expecting better prospects in future for the company. During the year under review Company given loan of Rs 2.80 crore bearing 18% interest per annum to M/s. BHEL Employees Model Mutually Aided Co-operative House Building Society Limited for meeting the shortfall of amount in paying stamp duty for registering plots in Society’s Name. Projects completed during the year 2014-15: - (1). Frangipani, Pudupakkam, and (2). Meeting House/Service Centre, Bangalore. Regarding Ongoing Projects: 23 Cr is yet to receive from IT park (Alpha City pro...